Page last updated: 2024-10-21

5,8,11,14-eicosatetraynoic acid and Alloxan Diabetes

5,8,11,14-eicosatetraynoic acid has been researched along with Alloxan Diabetes in 3 studies

5,8,11,14-Eicosatetraynoic Acid: A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E(2) and F(2a).

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iida, N1
Iida, R1
Takeyama, N1
Tanaka, T1
Waters, KM1
Ntambi, JM1
Myers, TO1
Messina, EJ1

Other Studies

3 other studies available for 5,8,11,14-eicosatetraynoic acid and Alloxan Diabetes

ArticleYear
Increased platelet aggregation and fatty acid oxidation in diabetic rats.
    Biochemistry and molecular biology international, 1993, Volume: 30, Issue:1

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Adenosine Diphosphate; Animals; Blood Platelets; Carnitine O-Palmit

1993
Polyunsaturated fatty acids inhibit hepatic stearoyl-CoA desaturase-1 gene in diabetic mice.
    Lipids, 1996, Volume: 31 Suppl

    Topics: 5,8,11,14-Eicosatetraynoic Acid; alpha-Linolenic Acid; Animals; Diabetes Mellitus, Experimental; Die

1996
Depressed arteriolar responsiveness to norepinephrine in streptozotocin-induced diabetes in the rat.
    Prostaglandins, 1996, Volume: 52, Issue:5

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Arachidonic Acid; Arterioles; Blood Glucose; Blood Pressur

1996